Delivery Order SPE2DB20D3103-SPE2DB24FL4G3

Award Date 10/26/23
Potential Completion Date 10/27/23
Potential Value $1.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,508.00 firm-fixed-price delivery order is for the supply of Potassium Chloride 10 MEQ/100 ML solution in 100 ML containers. The contract has no set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
This federal contract award, with ID SPE2DB20D3103|SPE2DB22FN9W4, is a delivery order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of Potassium Chloride 10% (20 MEQ/15ML) unit dose 15ML, with a ceiling value of $1,998.24. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is a for-profit organization registered in the System for Award Management (SAM.gov). The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,525.52 delivery order is for the supply of Potassium Chloride Injection, a critical medical product used to treat potassium deficiency. The contract is a firm-fixed-price delivery order with a completion date of May 12, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,066.40 firm fixed-price delivery order is for the supply of Potassium Chloride Extended Release 20 MEQ Tablets in 500-count bottles. The contract has an ultimate completion date of May 7, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,104.43 firm fixed-price delivery order is for the supply of 4560970833 potassium chloride extended-release 8 milliequivalent (MEQ) tablets in 500-count bottles. The contract has a performance period ending on May 18, 2023. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of Potassium Chloride 10% (20 MEQ/15ML) 473ML to the Defense Logistics Agency (DLA). The $1,456.34 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 4, 2024, with a completion date of September 5, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up to...
This federal contract award, SPE2DX15D1022|SPE2DX25FUYTF, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $8,854.60 firm fixed-price delivery order is for the supply of 4,566,133,855 units of 10% potassium chloride in 15 ml cups, with a period of performance through October 18, 2024. Amerisourcebergen is a large pharmaceutical distributor and healthcare solutions provider that maintains a $999,999,999 Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of potassium chloride extended-release tablets. The $3,905.52 firm-fixed-price delivery order has a completion date of November 14, 2022 and was awarded on November 10, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of potassium chloride medication in 15 mL cups. The contract has a ceiling value of $2,189.27 and a completion date of February 3, 2025. It is a firm fixed-price contract type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999 through November 2026, which serves as a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,542.26, is for the delivery of 4566803855 - POTASSIUM CL 10 MEQ/100 ML SOL 100ML, a medical supply item. The contract has an ultimate completion date of December 30, 2024. The award was not designated with a set-aside requirement, indicating open...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FL4G3
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,097.75 firm fixed-price delivery order is for the supply of Potassium Chloride 10 mEq/100 mL solution in 100 mL containers.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. This IDC, which runs through November 2026, enables the efficient procurement of critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 12:36 PM